Frauke joined HERC as a senior researcher in May 2017. Her research interests include the economic analysis of lifestyle choices and implications for public health policy with a special focus on obesity; preference elicitation by means of discrete choice experiments; and economic evaluations of health care and public health interventions. She is currently working on a number of economic evaluations alongside clinical trials in diabetic and pre-diabetic populations.
She has previously held appointments at Hannover Medical School (MHH), the University of Aberdeen, Brunel University, and the Royal College of Obstetricians & Gynaecologists where she contributed to the development of NICE guidelines. Prior to her appointment at HERC, she worked at the Health Economics Group within the Institute of Health & Society at Newcastle University where she was involved in a number of economic evaluations for public health interventions and conducted some preference elicitation work.
Lifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trial
Becker F. et al, (2018), DIABETOLOGIA, 61, S366 - S366
Impact of exenatide on medical costs and health utilities in type 2 diabetes: experience from EXSCEL
Reed SD. et al, (2018), DIABETOLOGIA, 61, S426 - S426
Comparison of medical resources, costs, and health utilities among patients with CHD and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation Trial (ACE)
Reed SD. et al, (2018), DIABETES, 67
Addison M. et al, (2018), Alcohol And Alcoholism